PPARA and non-small cell lung carcinoma: Conversely, PPARα activation with Wyeth-14,643 or fenofibrate was also reported to inhibit endothelial cell growth and non-small cell lung cancer (NSCLC) progression via binding to the PPER area in the promoter of mouse Cyp2c44 [12, 13, 16].